Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-05-01
1989-11-07
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514912, A61K 3142
Patent
active
048793043
ABSTRACT:
The present invention relates to novel therapeutic opthalmic compositions containing polydimethylsiloxane, and a process for preparing such ophthalmic compositions.
REFERENCES:
patent: 2727846 (1955-12-01), Talbot
patent: 3880996 (1975-04-01), Fisher
patent: 3993073 (1976-11-01), Zaffaroni
patent: 4012497 (1977-03-01), Schopflin
patent: 4705798 (1987-11-01), Schoenwald et al.
Chem. Abst. 105: 232,383(s) (1986),-Korbar-Smid.
Chem. Abst. 105: 232,320(u) (1986)-Chien et al.
European Search Report in EPO No. 88101032.6.
Chem. Abstract, vol. 104, #174346Y.
Johansen and Bundgaard, J. Pharm. Sci, 72: 1294, (1983).
Dow Corning 360 Medical Fluid.
Angelini Pharmaceuticals Ltd.
Fay Zohreh A.
Robinson Douglas W.
LandOfFree
Ophthalmic compositions and process for preparing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmic compositions and process for preparing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic compositions and process for preparing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-84096